GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » 12-1 Month Momentum %

ValiRx (LSE:VAL) 12-1 Month Momentum % : -62.44% (As of Apr. 25, 2024)


View and export this data going back to 2000. Start your Free Trial

What is ValiRx 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-25), ValiRx's 12-1 Month Momentum % is -62.44%.

The industry rank for ValiRx's 12-1 Month Momentum % or its related term are showing as below:

LSE:VAL's 12-1 Month Momentum % is ranked worse than
82.55% of 1484 companies
in the Biotechnology industry
Industry Median: -22.18 vs LSE:VAL: -62.44

Competitive Comparison of ValiRx's 12-1 Month Momentum %

For the Biotechnology subindustry, ValiRx's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ValiRx's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where ValiRx's 12-1 Month Momentum % falls into.



ValiRx  (LSE:VAL) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ValiRx  (LSE:VAL) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


ValiRx 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of ValiRx's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


ValiRx (LSE:VAL) Business Description

Traded in Other Exchanges
Address
4 Barling Way, Eliot Park Innovation Centre, Nuneaton, GBR, CV10 7RH
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.

ValiRx (LSE:VAL) Headlines

From GuruFocus

Oak Hill Advisors LP Reduces Stake in Valaris Ltd

By GuruFocus Research 08-10-2023

Valaris to Present at the BofA Securities Global Energy Conference

By Business Wire Business Wire 11-14-2022

Valaris Provides Quarterly Fleet Status Report

By Business Wire Business Wire 10-31-2022

Valaris Announces Contract Awards and Fleet Status Updates

By Business Wire Business Wire 12-16-2022

Valaris Provides Fleet Status Report

By Business Wire Business Wire 05-02-2023

Valaris Provides Fleet Status Report

By Business Wire Business Wire 01-13-2023

Valaris Provides Fleet Status Report

By Business Wire 08-02-2023